English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  1. Home
  2. Stocks
  3. Kilitch Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Kilitch Drugs(I)

    Small Cap
    ₹334.4
    -10 (-2.9%)
    29 June, 2024 03:29 BSE: 524500 NSE: KILITCHISIN: INE729D01010

    Start SIP in Kilitch Drugs(I)

    Start SIP

    Kilitch Drugs(I) Performance

    Day Range

    • Low 333
    • High 355
    ₹ 334

    52 Week Range

    • Low 175
    • High 470
    ₹ 334
    • Open Price355
    • Previous Close344
    • Volume15161

    Kilitch Drugs(I) Share Price

    • Over 1 Month +1.5%
    • Over 3 Month -14.17%
    • Over 6 Month -9.01%
    • Over 1 Year +73.89%

    Kilitch Drugs(I) Key Statistics

    P/E Ratio 36.8
    PEG Ratio 0.9
    Market Cap Cr 538
    Price to Book Ratio 3.1
    EPS 10.9
    Dividend 0
    Relative Strength Index 49.88
    Money Flow Index 57.6
    MACD Signal -3.44
    Average True Range 17.11
    Kilitch Drugs(I) Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3930323143
    Operating Expenses Qtr Cr 3426262637
    Operating Profit Qtr Cr 54657
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 01000
    Tax Qtr Cr 21212
    Net Profit Qtr Cr 45445
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 138122
    Operating Expenses Annual Cr 111101
    Operating Profit Annual in Cr 2017
    Depreciation Cr 11
    Interest Annual Cr 21
    Tax Annual Cr 64
    Net Profit Annual Cr 1816
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -16
    Cash from Investing Activity Annual Cr -106
    Cash from Financing Annual Activity Cr 113
    Net Cash Flow Annual Cr 15
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 223196
    Fixed Assets Annual Cr 2216
    Total Non Current Assets Annual Cr 146138
    Total Current Assets Annual Cr 141115
    Total Assets Annual Cr 287252
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 139126
    ROE Annual % 88
    ROCE Annual % 1110
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2018
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 4532413745
    Operating Expenses Qtr Cr 3830333039
    Operating Profit Qtr Cr 72966
    Depreciation Qtr Cr 11111
    Interest Qtr Cr 12211
    Tax Qtr Cr 21212
    Net Profit Qtr Cr 43534
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 159143
    Operating Expenses Annual Cr 130122
    Operating Profit Annual in Cr 2418
    Depreciation Cr 34
    Interest Annual Cr 65
    Tax Annual Cr 64
    Net Profit Annual Cr 1510
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 03
    Cash from Investing Activity Annual Cr -108
    Cash from Financing Annual Activity Cr 9-1
    Net Cash Flow Annual Cr 10
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 176152
    Fixed Assets Annual Cr 6868
    Total Non Current Assets Annual Cr 9493
    Total Current Assets Annual Cr 146126
    Total Assets Annual Cr 240220
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 10997
    ROE Annual % 87
    ROCE Annual % 1411
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1915
    Invest in Kilitch Drugs(I)

    Kilitch Drugs(I) Technicals

    EMA & SMA

    Current Price
    ₹334.4
    -10 (-2.9%)
    pointer
    • Bullish Moving Average
    • ___
    • 8
    • Bearish Moving Average
    • ___
    • 8
    • 20 Day
    • ₹333.25
    • 50 Day
    • ₹340.93
    • 100 Day
    • ₹346.30
    • 200 Day
    • ₹327.16
    • 20 Day
    • ₹330.74
    • 50 Day
    • ₹339.26
    • 100 Day
    • ₹363.19
    • 200 Day
    • ₹340.91

    Kilitch Drugs(I) Resistance and Support

    PIVOT
    ₹340.77
    Resistance
    First Resistance 348.53
    Second Resistance 362.67
    Third Resistance 370.43
    RSI 49.88
    MFI 57.60
    MACD Single Line -3.44
    MACD -1.37
    Support
    First Support 326.63
    Second Support 318.87
    Third Supoort 304.73

    Kilitch Drugs(I) Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 18,182 1,342,195 73.82
    Week 27,729 2,054,704 74.1
    1 Month 17,089 1,277,915 74.78
    6 Month 17,579 1,215,908 69.17

    Kilitch Drugs(I) Result Highlights

    Kilitch Drugs(I) Synopsis

    NSE-Medical-Diversified

    Kilitch Drugs(I) is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 117.78 Cr. and Equity Capital is Rs. 15.58 Cr. for the Year ended 31/03/2023. Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718.
    Market Cap 554
    Sales 132
    Shares in Float 0.50
    No of funds 2
    Yield 0.51
    Book Value 2.47
    U/D Vol ratio 1.2
    LTDebt / Equity
    Alpha 0.09
    Beta 0.98

    Kilitch Drugs(I) Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23
    Promoters 69.23%69.23%69.23%
    Mutual Funds
    Insurance Companies
    Foreign Portfolio Investors
    Financial Institutions/ Banks
    Individual Investors 25.38%26.13%26.13%
    Others 5.39%4.64%4.64%

    Kilitch Drugs(I) Management

    Name Designation
    Mr. Mukund P Mehta Managing Director
    Mr. Bhavin Mukund Mehta Whole Time Director
    Mrs. Mira B Mehta Whole Time Director
    Mr. Hemang J Engineer Independent Director
    Mr. Venkita Subramanian Rajan Independent Director
    Prof. Vasudev Krishna Murti Independent Director

    Kilitch Drugs(I) Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Kilitch Drugs(I) Corporate Action

    Date Purpose Remarks
    2024-05-27 Quarterly Results
    2024-02-08 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-11 Quarterly Results
    2023-07-22 Others To consider and approve conversion of warrants into the equity shares of the Company to the specified person only. per share(5%)Final Dividend

    Kilitch Drugs(I) MF Shareholding

    Name Amount(cr)

    Kilitch Drugs(I) FAQs

    What is Share Price of Kilitch Drugs(I) ?

    Kilitch Drugs(I) share price is ₹334 As on 29 June, 2024 | 03:15

    What is the Market Cap of Kilitch Drugs(I) ?

    The Market Cap of Kilitch Drugs(I) is ₹537.8 Cr As on 29 June, 2024 | 03:15

    What is the P/E ratio of Kilitch Drugs(I) ?

    The P/E ratio of Kilitch Drugs(I) is 36.8 As on 29 June, 2024 | 03:15

    What is the PB ratio of Kilitch Drugs(I) ?

    The PB ratio of Kilitch Drugs(I) is 3.1 As on 29 June, 2024 | 03:15

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.